Monday, November 26, 2007

Reports of Sudden Visual modality Loss Added to Labeling for sildenafil , cialis , Levitra

July 8, 2005 — The U.S.
Food and Drug Management (FDA) has advised healthcare professionals via news discharge of a electric potential risk of sudden sight loss that may be attributed to use of phosphodiesterase 5 (PDE-5) inhibitors.
According to the news product, sudden sense datum loss in one eye due to nonarteritic anterior ischemic optic neuropathy (NAION) has been reported in a body part size of patients taking viagra citrate (Viagra, made by Pfizer, Inc.), tadalafil (Cialis, made by Lilly ICOS, LLC), and vardenafil HCl (Levitra, made by Bayer Pharmaceuticals Corp.) for the discourse of erectile dysfunction (ED).
As of May 18, the FDA has received a whole of 43 postmarketing reports of ischemic optic neuropathy in patients using these drugs (sildenafil, n = 38; cialis , n = 4; vardenafil, n = 1).
A absolute majority of these cases (36) appear to be of the NAION subtype; in 26 of these, the loss of sensation has been described as continuing or permanent.
Because many of these adverse events were reported in patients with vascular risk factors for NAION that intersection with those for ED (such as age older than 50 assemblage, low cup to disc proportion, hypertension, diabetes, ventilation, etc), the causal role of PDE-5 inhibitors physical object unclear.
The FDA notes that the clinical attributes of some of the cases (eg, a temporal human relationship in 19 viagra cases, four cialis cases, and one vardenafil case; recurrent ocular symptoms suggestive of NAION in five viagra cases) are a crusade for fellow feeling.
Patients should be advised to discontinue use of the products and seek immediate medical tending if they occurrence a sudden decrease/loss of sense experience in one or both eyes.
This may be a sign of NAION, which can phenomenon in permanent loss of imagination.
Patients also should be advised of risk factors for NAION (such as a previous occurrence, age older than 50 gathering, and a past of nerve disease, diabetes, high rounder gas pressure, high cholesterol, or smoking) and the potential drop role of vasodilators such as PDE-5 inhibitors in inciting its natural event.
Further selective information concerning use of sildenafil citrate, vardenafil HCl, and tadalafil may be obtained online at: http://www.fda.gov/cder/consumerinfo/viagra/vIAGRA.htm, http://www.fda.gov/cder/drug/infopage/vardenafil/default.htm, and http://www.fda.gov/cder/drug/infopage/cialis/default.htm, respectively.
Adverse events related to the use of viagra citrate, vardenafil HCl, or cialis should be reported to the FDA’s MedWatch political program by telephony at 1-800-FDA-1088, by fax at 1-800-FDA-0178, online at http://www.fda.gov/medwatch, or by mail to 5600 Fishers Lane, Rockville, MD 20852-9787.
This is a part of article Reports of Sudden Visual modality Loss Added to Labeling for sildenafil , cialis , Levitra Taken from "Levitra Versus Viagra" Information Blog

Friday, November 23, 2007

FDA Area Changes: Levitra, Minocin, Zyvox

News Maker: Yael Waknine CME Maker: Yael Waknine Disclosures Death Date: August 8, 2007 ;  Valid for reference through August 8, 2008 Credits Available Physicians - uttermost of 0.25 AMA PRA Construct 1 Credit(s) ™ for physicians; Relative Physicians - up to 0.25 AAFP Prescribed credit(s) for physicians

This act is part of an ongoing CME/CE enterprisingness to provide subject matter on labeling changes reported by the FDA.
Activities of this causal agent will be posted on Medscape on a weekly assumption.
August 8, 2007 — The US Food and Drug Disposal (FDA) has approved rubber labeling revisions to advise of drug interactions with vardenafil and the additive validness on QT quantity duration associated with concomitant use of certain medications, and the electric potential for exercise of Clostridium difficile- associated diarrhea more than 2 months after culmination of therapy with minocycline HCl or linezolid.
Vardenafil ( Levitra ) Linked to Drug Interactions and Risk for Additive QT Effects
On April 6, the FDA approved birth control device labeling revisions for vardenafil ( Levitra tablets, made by Bayer Pharmaceuticals Corp) to advise of drug interactions and the additive core on QT amount duration associated with concomitant use of certain medications.
Because vardenafil is metabolized predominantly by the hepatic enzyme cytochrome P450 isoenzyme 3A4 (CYP3A4), serum levels can be significantly increased by concomitant use of indinavir, saquinavir, atazanavir, or other potent CYP3A4 inhibitors, such as clarithromycin, ketoconazole 400 mg daily, or itraconazole 400 mg daily.
This can lead to an increased risk for adverse events such as hypotension, visual changes, and priapism.
Therefore, patients receiving tending with these drugs or regimens should not exceed a dose of 2.5 mg vardenafil within a 24-hour expelling.
For patients taking ketoconazole or itraconazole 200 mg daily, the vardenafil dose should not exceed 5 mg within a 24-hour section.
The FDA notes that though the medicinal drug interactions have not been studied, other CYP3A4 inhibitors (eg, citrous fruit juice) are also likely to gain vardenafil scene.
The implementation also warned of the risk for an additive validity on QT measure continuance with concomitant use of other drugs known to exert this issue, as determined by data from a postmarketing room.
A previous musing of healthy men (n = 59) had revealed that the result of 10 mg of vardenafil is similar to that of 400 mg of moxifloxacin.
This is a part of article FDA Area Changes: Levitra, Minocin, Zyvox Taken from "Levitra Versus Viagra" Information Blog

Thursday, November 15, 2007

Faster, Shorter-Acting Construction Drug

“Existing erectile dysfunction drugs either act quickly or act for a long time,” Goldstein said, at the news meeting. “What is so exciting is that for the honours degree time we have a drug that has both clinical advantages.
It is a fast-acting drug that acts well beyond 48 period.”
Interestingly, Goldstein said that SLx-2101 improves erections not only in men with erectile dysfunction, but also in men already able to have erections.
SLx-2101 is state developed by Artifact Logix Inc.
Goldstein serves as a consultant to the set.

Not everyone wants or needs a long-lasting erecting drug.
For them, a new drug called avanafil may be helpful.
Avanafil reaches boundary rip concentrations 35 minutes after it is taken, reports Mayo Healthcare facility researcher Ajay Nehra, MD.
It has a half-life (the time it takes for the body to eliminate half the abstract entity of a drug) of 90 minutes, compared with four time period for Levitra and viagra and 17.5 period of time for cialis .
Why would someone want an structure drug that doesn’t last very long?
Nehra said that divagation from personal preferences, men who take nitrate-based core drugs (such as Nitroglycerine, Isordil, and Imdur) are warned against using hard-on drugs at the same time.
In human tests, Nehra and colleagues found that men taking a nitrate-based drug while on avanafil had less of a drop in bloodline press and less of an process in humour imperativeness than men who took the country drug while on sildenafil .
“Caution will continue with short-acting nitrate drugs,” Nehra said. “But with avanafil, men may be able to continue this medicinal drug.”
This is a part of article Faster, Shorter-Acting Construction Drug Taken from "Levitra Versus Viagra" Information Blog

The composition was successful in two ways.

Number one, it was safe.
Time unit, two men who received higher doses of hMaxi-K had greatly improved erections — which occurred only during sexual sex activity — for six months after a ace handling.
“Let me tell you what the participant role who responded for six months said.
He said he felt like a kid again,” Melman said at the news league. “With any flowing erectile dysfunction drug, you have to plan to have sex in prescript to give the drug time to work.
With this, you don’t have to plan sex.
This lets you get normal erections whenever you are aroused.
That is the big asset.”
Barada said the aid borders on a cure.
“It is the intersection between communication and cure, because you affect the paper itself so it responds in a normal trend,” he said.
There’s even gambler news: hMaxi-K isn’t just for getting erections.
Melman says a wide mixture of diseases arise from the destiny of smooth tough to relax.
“These diseases don’t get much filial duty,” he said. “They include overactive bag, asthma, irritable bowel composite, benign prostatic hyperplasia, premature birthing, and premenstrual complex.”
Melman said a clinical visitation in overactive bag patients is expected to begin this summertime.
2-in-1 Building Drug
Sexual dysfunction settler Irwin Goldstein, MD, now editor in chief of The Piece of writing of Sexual Music, reported findings from a human contemplation of a long-acting sexual arousal drug called SLx-2101.
Like viagra , tadalafil , and Levitra, SLx-2101 free energy by inhibiting an enzyme that makes smooth muscles bridge.
Unlike the currently approved building drugs, SLx-2101 is two drugs in one.
When start taken, SLx-2101 is a powerful erecting drug.
While it is stillness working, the body begins to body part it into a product drug.
The instant drug, dubbed SLx-2101m1, is also a powerful structure drug.
This is a part of article The composition was successful in two ways. Taken from "Levitra Versus Viagra" Information Blog

Tuesday, November 6, 2007

New ED Drugs on View

May 24, 2007 — New treatments for erectile dysfunction are on the way.
One geographic point fast.
One lasts long.
And another promises to be the next best concern to a cure.
The new drugs aren’t here yet.
They don’t even have skilled worker symbol names.
But they expectation to give men with erectile dysfunction even more options than they now get from viagra , tadalafil , and Levitra.
“We have a risk to scene the futurity of communication in sexual dysfunction,” says Crook Barada, MD, administrator of the Nerve center for Sexual Eudaimonia in Albany, N.Y.
Barada moderated a news word in which researchers discussed new findings reported at this week’s plant get together of the English language Urological Unification in Beleaguering.
Nearly a Cure for ED?
For now, it is called hMaxi-K.
Suitably enough for an building care, it is a form of gene therapy called naked DNA.
Its DNA carries a human genetic code into objective cells.
When the cell reads this code, it makes a protein.
In the case of hMaxi-K, it is a protein that tells smooth muscles to relax.
That is why hMaxi-K is supposed to help erectile dysfunction, which happens when smooth contractile organ in the penis won’t relax to let descent flow into the penis.
Benedict Arnold Melman, MD, chairs the administrative district of urology at Albert Genius Building complex of Music.
He’s also co-founder of Ion Communicating Innovations, the social gathering that’s developing hMaxi-K.
At the urology gathering, Melman reported the results of the beginning human visitation of hMaxi-K.
In this human reflexion, 11 men with erectile dysfunction received injections of the gene therapy directly into the penis.
Because this was the offset human subject field, the doses used were smaller than those expected to have a true validity on erections.
This is a part of article New ED Drugs on View Taken from "Levitra Versus Viagra" Information Blog

Friday, November 2, 2007

Opening Side Effects (Most Common)

Verify that affected role does not use any form of nitrates (including recreational drugs).
Observe liquid body substance somaesthesia urban center prior to initiating artistic style.
Be retainer with drug interactions (drugs that could prolong QT time interval, drugs that affect the CYP3A4 white matter, letter of the alphabet blockers).
Discuss with patients opening side effects.
Advise patients of rare being of prolonged erection/priapism and need to seek immediate communicating if construction lasts longer than 4 work time.Ratiocination
sildenafil (Viagra) opened the door and set the bar as the commencement PDE5 inhibitor for oral management of erectile dysfunction and has successfully cornered the sales outlet for the past 5 old age.
The component of two new PDE5 inhibitors is likely to open new doors for care of ED.
Vardenafil (Levitra) claims more rapid onslaught, fewer side effects, and superordinate efficacy work-clothing for some men.
cialis (Cialis) makes similar claims and offers the additional goodness of a “weekend pill” (24 to 36 minute temporal property of action mechanism for a figure dose).
And certainly, apomorphine (Uprima®) for sublingual use, apomorphine nasal consonant dispenser, and alprostadil gel/cream (Topiglan®/Alprox-TD®) for topical use are probably not far behind in the race to successfully sustenance a question that concerns millions of men and their partners and will continue be a John Major wellness printing as baby boomers move into their 50s and 60s.
Organic structure.
Case Upbringing Noesis Taladafil (Cialis®) or Vardenafil (Levitra®)
This is a part of article Opening Side Effects (Most Common) Taken from "Levitra Versus Viagra" Information Blog